SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Eclectus who wrote (707)3/1/2000 4:51:00 PM
From: Charles Tutt  Read Replies (1) | Respond to of 1298
 
Ta da Moon, Alice!

I dunno. I think today makes a 10-banger for me, though, so I already can't complain.

JMHO.



To: Eclectus who wrote (707)3/1/2000 4:58:00 PM
From: Steeny  Read Replies (2) | Respond to of 1298
 
I don't dare to guess on CEGE. I've never had good timing picking tops. However, it looks cheap relative to other biotechs. It seems as though fund money is accumulating here. The most recent information I have is 12/99 at which time Putnam, Barclays Global, Morgan grenfell, Aeltus Investment were all accumulating. Only 32 million shares outstanding. If institutions are buying & holding right now, one can only guess where she goes...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News